India Globalization Capital/$IGC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About India Globalization Capital
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Ticker
$IGC
Sector
Primary listing
AMEX
Industry
Pharmaceuticals
Headquarters
Employees
70
ISIN
US45408X3089
Website
IGC Metrics
BasicAdvanced
$35M
-
-$0.09
1.48
-
Price and volume
Market cap
$35M
Beta
1.48
52-week high
$0.46
52-week low
$0.25
Average daily volume
4.2M
Financial strength
Current ratio
1.283
Quick ratio
0.214
Long term debt to equity
2.275
Total debt to equity
3.76
Profitability
EBITDA (TTM)
-6.828
Gross margin (TTM)
48.70%
Net profit margin (TTM)
-560.27%
Operating margin (TTM)
-585.84%
Revenue per employee (TTM)
$20,000
Management effectiveness
Return on assets (TTM)
-49.91%
Return on equity (TTM)
-104.33%
Valuation
Price to revenue (TTM)
24.985
Price to book
5.3
Price to tangible book (TTM)
7.5
Price to free cash flow (TTM)
-6.018
Free cash flow yield (TTM)
-16.62%
Free cash flow per share (TTM)
-6.90%
Growth
Revenue change (TTM)
-5.50%
Earnings per share change (TTM)
-57.88%
3-year revenue growth (CAGR)
47.38%
10-year revenue growth (CAGR)
-16.46%
3-year earnings per share growth (CAGR)
-32.33%
10-year earnings per share growth (CAGR)
-11.41%
IGC News
AllArticlesVideos
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection
Accesswire·20 hours ago
IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation
Accesswire·2 weeks ago
IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for India Globalization Capital stock?
India Globalization Capital (IGC) has a market cap of $35M as of July 11, 2025.
What is the P/E ratio for India Globalization Capital stock?
The price to earnings (P/E) ratio for India Globalization Capital (IGC) stock is 0 as of July 11, 2025.
Does India Globalization Capital stock pay dividends?
No, India Globalization Capital (IGC) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next India Globalization Capital dividend payment date?
India Globalization Capital (IGC) stock does not pay dividends to its shareholders.
What is the beta indicator for India Globalization Capital?
India Globalization Capital (IGC) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.